Scholarlink

Background <p>Asthma is a heterogeneous inflammatory airway disorder associated with complex metabolic alterations. Despite significant advances in diagnosis and treatment, its prevalence and disease burden continue to rise, particularly among children. Recent research reveals that metabolic alterations play a crucial role in the disease development, severity, and treatment response. This study aimed to investigate dysregulation of serum metabolites in children with moderate-to-severe asthma compared with healthy controls using an untargeted metabolomic profiling approach.</p> Results <p>Hierarchical clustering and stratified analyses identified distinct metabolic signatures differentiating asthmatic patients from controls, with progressive changes reflecting increasing disease severity. Thirty-nine metabolites were found to be commonly dysregulated in moderate and severe asthma. Notably, adenosine and orotic acid were significantly upregulated, while 5-methoxytryptophol (5-MTX) was markedly downregulated, showing its lowest levels in severe asthma. Pathway enrichment analysis revealed significant disruptions in pyrimidine, amino acid, and urea cycle pathways.</p> Conclusions <p>The identified metabolites and disrupted metabolic pathways may offer potential biomarkers of disease severity and provide insights to guide future therapeutic strategies. However, their utility in clinical practice as diagnostic or prognostic biomarkers across the full spectrum of asthma requires further validation in independent cohorts that include children with mild disease.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Untargeted metabolomics profiling of childhood asthma: linking metabolic pattern to disease severity

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月16日

查看全文
  • Shereen M. Aleidi,
  • Yousra A. Hagyousif,
  • Basma Majed Sharaf,
  • Fatema Alzahraa Almasri,
  • Montaha AL-Iede,
  • Enas Al Zayadneh,
  • Ahmad Y. Abuhelwa,
  • Waseem El-Huneidi,
  • Zainab Al Shareef,
  • Eman Abu-Gharbieh,
  • Karem H. Alzoubi,
  • Yasser Bustanji,
  • Mohammad H. Semreen

摘要

Background

Asthma is a heterogeneous inflammatory airway disorder associated with complex metabolic alterations. Despite significant advances in diagnosis and treatment, its prevalence and disease burden continue to rise, particularly among children. Recent research reveals that metabolic alterations play a crucial role in the disease development, severity, and treatment response. This study aimed to investigate dysregulation of serum metabolites in children with moderate-to-severe asthma compared with healthy controls using an untargeted metabolomic profiling approach.

Results

Hierarchical clustering and stratified analyses identified distinct metabolic signatures differentiating asthmatic patients from controls, with progressive changes reflecting increasing disease severity. Thirty-nine metabolites were found to be commonly dysregulated in moderate and severe asthma. Notably, adenosine and orotic acid were significantly upregulated, while 5-methoxytryptophol (5-MTX) was markedly downregulated, showing its lowest levels in severe asthma. Pathway enrichment analysis revealed significant disruptions in pyrimidine, amino acid, and urea cycle pathways.

Conclusions

The identified metabolites and disrupted metabolic pathways may offer potential biomarkers of disease severity and provide insights to guide future therapeutic strategies. However, their utility in clinical practice as diagnostic or prognostic biomarkers across the full spectrum of asthma requires further validation in independent cohorts that include children with mild disease.